Waters (WAT) Cash from Financing Activities (2009 - 2026)
Waters (WAT) posted quarterly Cash from Financing Activities of -$213.0 million for Q2 2026, down 23.12% year-over-year from -$277.1 million in Q2 2025, and down 6484.89% on a QoQ basis from $3.3 million in Q4 2025.
Waters (WAT) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Waters (WAT) has reported Cash from Financing Activities for 18 consecutive years, with -$213.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash from Financing Activities fell 23.12% year-over-year to -$213.0 million; the TTM figure through Apr 2026 stood at -$277.2 million (up 52.0% YoY), while the FY2025 annual figure was -$237.2 million, up 65.95% from the prior year.
- Cash from Financing Activities came in at -$213.0 million for Q2 2026 at Waters, down from $3.3 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $3.3 million in Q4 2025, with the low at -$292.2 million in Q1 2024.
- Average Cash from Financing Activities over 5 years is -$125.2 million, with a median of -$122.0 million recorded in 2023.
- Across the five-year window, Cash from Financing Activities plunged 55.81% in 2024 and soared 101.72% in 2025, its largest moves.
- Year by year, Cash from Financing Activities stood at -$111.4 million in 2022, then retreated by 17.09% to -$130.5 million in 2023, then sank by 48.35% to -$193.6 million in 2024, then jumped by 101.72% to $3.3 million in 2025, then sank by 6484.89% to -$213.0 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered -$213.0 million, $3.3 million, and -$66.3 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 3.76 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -144.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -433.00 Mn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Quest Diagnostics | 23.76 Bn | 23.67 Bn | 942.00 Mn | -152.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -213.00 Mn |
| Apr 4, 2026 | -213.00 Mn |
| Dec 31, 2025 | 3.34 Mn |
| Dec 31, 2025 | 3.34 Mn |
| Sep 27, 2025 | -66.27 Mn |
| Sep 27, 2025 | -66.27 Mn |
| Jun 28, 2025 | -1.28 Mn |
| Jun 28, 2025 | -1.28 Mn |
| Mar 29, 2025 | -173.00 Mn |
| Mar 29, 2025 | -173.00 Mn |
| Dec 31, 2024 | -193.58 Mn |
| Dec 31, 2024 | -193.58 Mn |
| Sep 28, 2024 | -176.88 Mn |
| Sep 28, 2024 | -176.88 Mn |
| Jun 29, 2024 | -34.04 Mn |
| Jun 29, 2024 | -34.04 Mn |
| Mar 30, 2024 | -292.18 Mn |
| Mar 30, 2024 | -292.18 Mn |
| Dec 31, 2023 | -130.49 Mn |
| Dec 31, 2023 | -130.49 Mn |